The Safe Hands of ICP-MS
Anna Cousens, Global Analytical BDM at Almac Sciences, discusses ICP-MS analysis and the importance of getting it right in drug development.
Almac Sciences – part of the Almac Group – provides integrated services from development to commercial scale for API and finished products and employs over 170 highly skilled analysts working in GMP/ GLP environments across the UK, Europe, and US. We spoke to Anna Cousens, Global Analytical Business Development Manager, about inductively coupled plasma MS (ICP-MS) and its importance in drug development.
Download to find out more.View Resource
Almac API, Chemical Development, Analytical & Solid State Services
Almac Sciences provides integrated services from development to commercial scale of advanced intermediates and Active Pharmaceutical Ingredients (API).
We provide a range of services for small molecules (including highly potent) and peptides. We have a proven track record of saving time and cost through the integration of our services and application of innovative biocatalysis and technology solutions.
We offer a full suite of analytical testing for a range of different product types including small molecules, peptides, biologics, conjugates, potent and controlled substances.
Our vast pool of scientific knowledge can help to overcome the analytical challenges that typically arise during drug development.